GlassScriptPhysician profile
David R Kelly
NPI 1245278043
$2,148.82
in general payments reported to CMS, 2019-2025
21 companies · $797 in 2025
The $797 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2021: $78.83 · 2022: $58.25 · 2023: $649 · 2024: $379 · 2025: $797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,825.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $504.65 | 2019-2023 | Xarelto |
| Ucb, INC. | $425.44 | 2022-2025 | Briviact, Rystiggo |
| Abbvie INC. | $199.23 | 2025 | |
| Janssen Biotech, INC. | $127.90 | 2025 | |
| Amgen INC. | $121.74 | 2025 | Uplizna |
| Alexion Pharmaceuticals, INC. | $120.50 | 2023 | Ultomiris |
| Novartis Pharmaceuticals Corporation | $115.74 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $77.67 | 2022-2024 | Andexxa |
| Boston Scientific Corporation | $63.55 | 2023-2024 | Watchman Access System |
| Sun Pharmaceutical Industries INC. | $63.43 | 2024-2025 | |
| Sk Life Science, INC. | $56.94 | 2025 | Xcopri |
| Leo Pharma INC. | $49.51 | 2024-2025 | Adbry |
| Chiesi USA, INC. | $39.48 | 2025 | Cleviprex |
| Medtronic, INC. | $33.40 | 2024 | Linq II |
| Janssen Scientific Affairs, LLC | $32.37 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $21.60 | 2025 | Onpattro |
| Ceribell, INC. | $21.17 | 2025 | Pocket Eeg Device |
| Organogenesis INC. | $21.02 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $18.37 | 2023 | Nuedexta |
| Integra Lifesciences Corporation | $17.74 | 2023 | Durasorb Monofilament Mesh |
| Ambu INC. | $17.37 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.